Breast cancer is the most diagnosed life-threatening cancer globally that disproportionately affects women from low- and middle-income countries (LMICs).

The primary objective of this initiative is to reduce breast cancer mortality by 2.5% and avoid 2.5 million deaths by 2040. To mitigate this health inequity and ensure better health outcomes, WHO along with C/Can have partnered to implement the GBCI strategic framework.

To reach its targets, the Partnership will leverage WHO’s global leadership with C/Can’s ‘’on-the-ground’’ experience in local networks among 13 major cities around the world. This innovative collaboration addressing cancer care access will benefit from the private sector’s support, resources, and expertise.

The GBCI framework was launched on International Women’s Day 2023 and aims to strengthen local and national cancer control and management programs, build stronger health systems, and empower women. Some of the initial capacity building and technical plans include:

• Training and dissemination of knowledge on the GBCI technical package
• Capacity building of health workers to prevent treatment abandonment
• Launch of city-level plans and implementation of the framework to ensure timely diagnostics and management
• Launch of patient journey optimization plans to reduce treatment abandonment.

This GBCI implementation group includes representation from WHO and C/Can. It also engages an industry advisory board for the seamless sharing of expertise and knowledge. The governance structure facilitates multi-stakeholder collaboration to achieve the shared goals of reducing the breast cancer burden and improving millions of lives in LMICs.